These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 18398360

  • 1. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB.
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [Abstract] [Full Text] [Related]

  • 2. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB, Verma V, Realini T, Prenner JL, Feuer WJ, Fechtner RD.
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 4. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA.
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L, Allingham RR, Singh I, Stinnett S, Fekrat S.
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [Abstract] [Full Text] [Related]

  • 7. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM, Montero JA, Amat P, Lugo FL.
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [Abstract] [Full Text] [Related]

  • 8. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M, Vu L, Whitson JT, He YG.
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
    Shukla D, Vidhya N, Prasad NM, Mahalakshmi R, Kolluru C, Krishnadas R.
    Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
    [Abstract] [Full Text] [Related]

  • 10. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T, Uemura A, Kita H, Sakamoto T.
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone acetonide and intraocular pressure.
    Smithen LM, Ober MD, Maranan L, Spaide RF.
    Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
    [Abstract] [Full Text] [Related]

  • 12. Complications of intravitreal steroid injections.
    Reichle ML.
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [Abstract] [Full Text] [Related]

  • 13. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
    Inatani M, Iwao K, Kawaji T, Hirano Y, Ogura Y, Hirooka K, Shiraga F, Nakanishi Y, Yamamoto H, Negi A, Shimonagano Y, Sakamoto T, Shima C, Matsumura M, Tanihara H.
    Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS, Vernon SA, Negi A.
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [Abstract] [Full Text] [Related]

  • 15. Short-term complications of intravitreal injection of triamcinolone acetonide.
    Roth DB, Realini T, Feuer WJ, Radhakrishnan R, Gloth J, Heimmel MR, Fechtner RD, Yarian DL, Green SN.
    Retina; 2008 Jan; 28(1):66-70. PubMed ID: 18185140
    [Abstract] [Full Text] [Related]

  • 16. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
    Mahar PS, Memon AS.
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
    [Abstract] [Full Text] [Related]

  • 17. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
    Galor A, Margolis R, Brasil OM, Perez VL, Kaiser PK, Sears JE, Lowder CY, Smith SD.
    Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
    [Abstract] [Full Text] [Related]

  • 18. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
    Gregori NZ, Rosenfeld PJ, Puliafito CA, Flynn HW, Lee JE, Mavrofrides EC, Smiddy WE, Murray TG, Berrocal AM, Scott IU, Gregori G.
    Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
    Breusegem C, Vandewalle E, Van Calster J, Stalmans I, Zeyen T.
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
    Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM.
    Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.